We describe a multiplexed highly sensitive method to detect cancer biomarkers using silica encapsulated phase change nanoparticles as thermal barcodes. During phase changes, nanoparticles absorb heat energy without much temperature rise and show sharp melting peaks ͑0.6°C͒. A series of phase change nanoparticles of metals or alloys can be synthesized in such a way that they melt between 100 and 700°C, thus the multiplicity could reach 1000. The method has high sensitivity ͑8 nM͒ that can be enhanced using materials with large latent heat, nanoparticles with large diameter, or reducing the grafting density of biomolecules on nanoparticles.
A major challenge of biomarker-based early detection of cancer is that some biomarkers ͑nucleic acids or proteins͒ exist at low concentration and are not effective in reflecting cancers.
1 Multiplexed highly sensitive detection of multiple biomarkers has been proposed to enhance the accuracy. 2 Nanoparticles with unique magnetic, electric, optical, and electrochemical signatures have been used to detect biomarkers with high sensitivity by converting biological events into physical signals that can be amplified, [3] [4] [5] [6] but the detection multiplicity is limited due to narrow detection range and wide peak. 7 Only one or few types of biomarkers can be detected each time, and screening one sample for multiple biomarkers takes a long time. Magnetic nanoparticles lack particle-specific property for multiplicity. 8 Electric measurement cannot distinguish two types of metallic nanoparticles. 9 Although few types of nanoparticles can be detected by electrochemical method, 10 the method spans several volts, and the peaks are too broad to offer large multiplicity. The absorbance peaks of optically active nanoparticles in the UVvisible region ͑400-900 nm͒ are broad with peak width at half height of 150 nm, [11] [12] [13] [14] which limits the detection capacity. In case of surface enhanced Raman spectroscopy where sharp peaks exist over a large range, the available Raman active dyes are limited, 15 the ratio of Raman "hot" nanoparticles is low, and quantitative signals are hard to obtain.
The solid to liquid phase change materials ͑PCM͒ have unique thermophysical properties. PCM can adsorb thermal energy without temperature rise during the melting process. As long as the solid phase exists, all adsorbed thermal energy is used to melt the solid phase, and the theoretical peak width is zero. 16 In practice, the heat transfer from the surrounding environment into the core of PCM takes time, and such delay in melting broadens the melting peak because the temperature scan is done at a constant rate ͑0.02-20°C / min͒. At normal condition, the peak width is less than 1°C. All materials exhibit reversible solid-liquid transitions at certain temperatures. The melting temperatures depend on atomic numbers ͑pure metals͒ and compositions ͑alloys͒ if the diameter of PCM materials is larger than critical sizes, where surface atoms play an important role in decreasing melting temperatures. 17 A variety of alloys melt in the operating range of thermal analysis equipment ͑100-700°C͒, 18 and PCM can be encapsulated inside shells to prevent the changes in compositions. 19 We have developed a multiplexed highly sensitive method to detect cancer biomarkers ͑i.e., oligonucleotides͒, where silica encapsulated phase change nanoparticles of metals is used as thermal barcodes. The silica shells do not melt due to its high melting temperature ͑1650°C͒. The thermal signals are read out by differential scanning calorimetry ͑DSC͒, where the melting temperatures and the latent heats of fusion are used to determine the existence and concentrations of biomarkers. The major steps of this method are ͑1͒ the immobilization of single strand DNA ͑ssDNA1͒ on silica shells of encapsulated PCM nanoparticles; ͑2͒ the immobilization of another ssDNA ͑ssDNA2͒ on magnetic nanoparticles; ͑3͒ the hybridization of target ssDNA at two ends with ssDNA1 and ssDNA2, which will connect encapsulated PCM nanoparticles and magnetic nanoparticles; ͑4͒ the magnetic separation of unhybridized target ssDNA and ssDNA1; and ͑5͒ the thermal readout of PCM nanoparticles. The sequence of ssDNA1 is 5Ј-TTA CAA TAA TCC ATT ATT ATT A/3ThioMC3-D-3Ј; that of target ssDNA is 5Ј-GAA TTA TTG TAA ACA CAG CAA CCA CAT-3Ј; and that of ss-DNA2 is 5Ј-/5Biosg/ATG TGG TTG CTG TGT-3Ј. These sequences are designed randomly and are representative for any genetic biomarkers.
The PCM nanoparticles are synthesized by the thermal decompositions of organometallic precursors. The precursor ͑bismuth acetate or cyclopentadienyl indium͒ is dissolved in ethylene glycol in the presence of polyvinylpyrrolidone ͑PVP͒. nitrogen. The reaction is quenched after 20 min by pouring the mixture into 200 ml ethanol precooled to 0°C. After centrifuging and washing the nanoparticles, the thermal decomposition of tetraethoxysilane ͑TEOS͒ is used to generate silica, where 3.5 ml ammonia hydroxide ͑28%͒ and 0.2 ml TEOS are added to 50 ml ethanol that contains 50 mg suspended nanoparticles. 22 The mixture is sonicated at 70°C for 1 h, followed by centrifuging and washing by ethanol. Figure 1͑a͒ is a scanning electron microscopy ͑SEM͒ image of bismuth nanoparticles. These nanoparticles are coated with ϳ20 nm silica as shown in the transmission electron micrograph ͑TEM͒ ͓Fig. 1͑b͔͒. The nanoparticles at room temperature have a crystalline structure as shown in selected area electron diffraction ͑SAED͒ pattern ͓Fig. 1͑c͔͒. Energy dispersive x-ray ͑EDX͒ analysis confirms the compositions of core and shell materials ͓Fig. 1͑d͔͒, where the signals of silicon and bismuth can be seen clearly. The solid to liquid phase changes are studied by using DSC, which is operated from 50 to 300°C at a ramp rate of 2°C / min. The DSC curves of encapsulated bismuth and indium nanoparticles show single peak with full width at half height of less than 1°C ͓Figs. 1͑e͒ and 1͑f͔͒ where the two peaks in each figure correspond to the melting and freezing of PCM cores as temperature increases and decreases. Although nanoparticles with diameter smaller than the critical diameter ͑10 nm͒ melt at lower temperatures, encapsulated nanoparticles made here have similar melting temperature as bulk materials due to their larger diameters. 23 The silica shell is first modified with amine-terminated monolayer by adding aminopropyltriethoxysilane to the suspension of encapsulated nanoparticles in toluene. After reacting for 3 h at room temperature, extra silane molecules are removed by centrifuging. The nanoparticles are resuspended in anhydrous dimethyl sulfoxide that contains N-succinimidyl ͑4-iodoacetyl͒ aminobenzoate ͑SIAB͒ and incubated to complete the reaction. After removing excess SIAB by centrifuging, nanoparticles are incubated with 3Ј thiolated ssDNA ͑ssDNA1͒ in a buffer ͑pH 8.0͒ at room temperature. 24 The ssDNA1 is complementary to one end of the target ssDNA. In order to modify magnetic nanoparticles with separating ssDNA ͑ssDNA2͒, which is complementary to the other end of the target ssDNA, avidin is conjugated with polyacrylic-acid-coated iron oxide nanoparticles ͑10 nm diameter͒. The suspension of avidin-modified magnetic nanoparticles is incubated with biotinylated oligonucleotides in a buffered solution ͑pH 7͒, and unbound ssDNA2 is removed by dialysis. The hybridization is done by incubating target ssDNA with excess amounts of ssDNA1 modified PCM nanoparticles, and ssDNA2 modified magnetic nanoparticles in a buffer solution ͑pH 7͒ at 37°C. After hybridization, the encapsulated PCM nanoparticles with unhybridized ssDNA1 are removed using NdFeB magnet, and the aggregates formed by the PCM nanoparticles and magnetic particles are transferred into aluminum pans and analyzed using a Perkin-Elmer DSC ͑DSC 7͒.
The melting peaks of encapsulated PCM nanoparticles are used for biomarker detections. For encapsulated indium nanoparticles, the width of the melting peak becomes smaller as the ramp rate of temperature decreases ͓Fig. 2͑a͔͒. A linear relation exists between the ramp rate and the peak width ͓Fig. 2͑b͔͒, where the smallest peak width among the studied ramp rates is ϳ0.6°C. The peak areas change with the ramp rates, probably due to the heat loss during heating process. In the case of encapsulated bismuth nanoparticles, the peak widths also depend on the ramp rate ͓Fig. 2͑c͔͒, and the relation between the ramp rate and the peak width is also linear ͓Fig. 2͑d͔͒. The similarity in both cases suggests that the peak width is mostly determined by the temperature ramp rate. At the peak width of 0.6°C, the number of thermal barcodes could reach 1000 from 100 to 700°C. Figure 2͑e͒ shows the melting curves of four aggregates of encapsulated bismuth nanoparticles and iron oxide nanoparticles formed after DNA hybridization. Although iron oxide does not melt during the thermal scan ͑melting temperature over 1000°C͒, it can change the heat transfer into PCM nanoparticles because of its low thermal conductivity, thus the melting peaks become asymmetric. As a result, the melting peaks shift toward high temperature side slight, especially at low target ssDNA concentrations, where the ratio of PCM nanoparticles to magnetic nanoparticles is low. The area of melting peak is proportional to the mass of PCM nanoparticles, and can be obtained by integrating the heat flow over the melting range. A linear relation exists between the heat fluxes and the target ssDNA concentrations ͓Fig. 2͑f͔͒, from which the lowest detectable concentration of target ssDNA is 8 nM. The detection sensitivity depends on the latent heat of PCM and the diameter of PCM nanoparticles, as well as the grafting density of ssDNA on PCM nanoparticles. For encapsulated nanoparticles of bismuth and indium, the areas of melting peaks are different even if the masses and the diameters of these nanoparticles are close to each other. Lastly, the encapsulated indium and bismuth nanoparticles are mixed at FIG. 1. ͑Color online͒ ͑a͒ SEM image of bare bismuth nanoparticles. ͑b͒ TEM image, ͑c͒ SEAD, and ͑d͒ EDX spectrum of encapsulated bismuth nanoparticles. ͑e͒ The DSC curves of encapsulated bismuth nanoparticles and ͑f͒ encapsulated indium nanoparticles.
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roughly the same concentrations, modified with ssDNA1, and used to detect target ssDNAs. The DSC curve shows two peaks with melting temperatures at 155 and 271°C, which correspond to the melting peaks of indium and bismuth, respectively. The peak area ͑i.e., heat flux͒ of indium is smaller than that of bismuth because the latent heat of indium ͑28 J/g͒ is smaller than that of bismuth ͑52 J/g͒. The ratio of integrated peak area ͑0.61͒ is close to the ratio of latent heats of indium and bismuth ͑0.54͒, meaning the chances of ss-DNA immobilizations, and hybridizations on these two types of nanoparticles are close to each other. The minimal detectable heat flux in the commercial DSC is determined by its root mean square noise ͑0.2 W͒, which corresponds to an energy flow of 0.2 J for 1°C wide peak at a ramp rate of 1°C / s. If bismuth nanoparticles of 200 nm diameter are used, the number of nanoparticles that can adsorb 0.2 J heat is 9 ϫ 10 4 . Providing one DNA double helix is formed on each nanoparticle in a 1 ml solution, the accordant concentration of target ssDNA is 1.5 ϫ 10 −16 M or 0.15 fM. The current detection limit is not as good as the theoretical one, probably because thousand of target ssDNA are attached on each nanoparticle. The detection sensitivity can be enhanced by using larger diameter particles, materials with large latent heats of fusion, or reducing the grafting density. Microcalorimetry can measure the formation enthalpy of DNA duplex, 25 but it cannot detect genetic biomarkers due to the sequence-independent enthalpy change. The proposed method works for turbid samples, and is immune to colored molecules, salts, or conductive materials, which do not change phase in the operating range. The interferences from organic carbon can be excluded by preheating samples. The detection capacity and analysis time can be optimized by changing ramp rate. In the case of fast scan, the temperature ramp rate can be 50°C / min, and an entire thermal scan from room temperature up to 1000°C takes only 20 min. Due to wide ranges of material choices, a one-to-one correspondence can be established between the melting temperatures of PCM nanoparticles and types of biomarkers, allowing easy readout of thermal signals. Lastly, detecting biomarkers in thermal space provides an alternative that is independent of the optical, electric, magnetic, and electrochemical properties of nanoparticles. The large thermal scan range, sharp melting peak, large latent heat, and diverse material choice pave the way to detect multiple low concentration noneffective biomarkers.
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FIG. 2. ͑Color online͒ ͑a͒
The melting peaks ͑b͒ and the relation of peak width and temperature ramp rate for encapsulated indium nanoparticles. ͑c͒ The melting peaks and ͑d͒ the relation of peak width and the ramp rate for encapsulated bismuth nanoparticles. ͑e͒ The melting peaks of encapsulated bismuth nanoparticles after the hybridization with target ssDNA. ͑f͒ The relation between peak area and the concentrations of target ssDNA ͑inset͒ and the DSC curve of encapsulated indium and bismuth nanoparticles collected in the same detection process.
